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This book has 2 goals. The first is to further the understanding of the biopsychosocial parameters of drug abuse and its negative consequences. The second is to review the prevention and cessation of substance abuse through modification of the neurobiological, cognitive, social, and larger socioenvironmental and physical environmental influences.
The first half of the book starts with an introduction to the extensive terminology associated with the continuum of drug use. A clarification of public terms such as street drug, hard and soft drugs, designer and club drugs is followed by more criteria-based definitions such as those of abuse and dependence listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the World Health Organization's International Classification of Diseases classifications. The authors highlight the current lack of differentiation between adolescent and adult substance abuse including, among adolescents, less physical dependence and physical problems, as well as different high-risk situations. The introduction concludes with a historical review of the disease concept of addiction, with alternatives suggested as well as a synopsis of drug abuse in the United States during the last 200 years.
The next section is a review of the major etiological components of drug abuse. Various integrative theories are presented, some well known to the medical reader such as the interaction of risk and protective factors and the biopsychosocial model, and some less so like the PACE (Pragmatics Attraction Communication Expectation) stage model or the interaction of distal and proximal factors. Four predictor domains are outlined: the neurobiologically relevant, the salient cognitive processes, the social interaction and close groups, and lastly the larger social and physical environment. The neurobiology domain is familiar to psychiatrists, but the chapter on potential thought distortions and the addictive thinking process is intriguing.
Regarding social predictors, one's intimate support system affects whether a person initiates drug use. The values and behaviours of parents and other role models, peer pressure, as well as the exposure with deviant subcultures will all influence drug use. The larger social environment can also be a predisposing factor either through the impact of physical surroundings, drug distribution routes, socioeconomic status or through cultural constructs including sex and ethnicity perceptions, as well as the pervasive influence of mass media and increasingly the worldwide web.
The second half of the book addresses the promotion and cessation of substance use along the 4 domains identified in the etiology. Neurobiologically relevant prevention programming involves addressing the genetic and neurotransmitter predisposition, strategies to delay exposure to drugs, as well as teaching skills to express one's self and enhance self-control. The related cessation strategy is essentially the pharmacotherapy of addiction.
Prevention strategies to address cognitive mediators and moderators of drug use include the counteraction of information errors, practicing decision-making, as well as enhanced awareness of belief-behaviour and context-situation distortions. Related therapeutic strategies include cognitive-behavioural techniques, cue exposure therapy, cognitive-oriented self-help recovery, and relapse prevention.
The close social settings and groups can also be mobilized to help correct adolescents' misconceptions, as well as providing a venue for practicing behavioural skills with corrective input from educators and peer feedback. A range of programs are reviewed that are school-, family-, or community unit-based to prevent the onset of drug use. The engagement of significant others to induce drug cessation, the 12-step fellowship to provide sober peer support and long-term aftercare, as well as the use of a therapeutic community are but a few examples of successful social cessation strategies.
The macrosocial environment is also a target for prevention. Supply reduction strategies constrain exposure to drugs. Media-based programming has the ability to reach a large audience and induce large scale beliefs and behaviour change. Access to cessation strategies is increasing in the justice system, in the workforce with employee assistance programs, and with the education of primary care providers in screening and brief interventions.
The book concludes with recommendations for future directions such as the need for a taxonomy of prevention and cessation strategies, more targeted programs for difficult ages or special populations, a consistency of approach across drugs and harnessing a rapidly changing technology facilitating transdisciplinary and translation work.
This book is an ambitious, scholarly compendium of many conceptual approaches. Many of the citations are the work of the 2 authors, who are well-funded and noted researchers in the field of social psychology and preventive medicine in the United States. The readers of this book are likely to be introduced to a brand new terminology derived from the social literature; this is not easy reading for a medical audience.
To me, the second half of the book is of particular value as it highlights the theoretical and applied connections between etiology and prevention-cessation strategies structured across 4 domains. Few books in the field have captured this interaction as well as this one. The price of the book is reasonable. 
Anxiety Disorders

Social Anxiety Disorder: Advances in Psychotherapy, Evidence-Based Practice
Reviewer rating: Very Good
Review by Diane McIntosh, MD, FRCPC Vancouver, British Columbia
In just fewer than 100 pages, the authors do what they set out to do in their book's preface. That is, " . . . to bridge the divide between the empirically supported treatments [for social anxiety disorder (SAD)] and day-to-day practice." The authors have not designed this book to challenge the cognitive-behavioural therapy (CBT) practitioner with a wealth of clinical experience treating SAD. However, its usefulness extends beyond the trainee, and would be helpful for psychiatrists and family doctors hoping to develop their understanding of SAD and their CBT skills. As well, this handbook was designed for other mental health professionals who have not had a great deal of experience diagnosing and treating SAD. Moreover, it makes a strong argument to clinicians for the existence of SAD, which is sometimes dismissed as shyness, with emphasis on the significant morbidity associated with SAD, and the need to diagnose and treat effectively.
Social Anxiety Disorder is divided into 6 chapters, which flow thoughtfully through the usual process most clinicians follow as they attempt to understand their patient. First, the authors review the typical phenomenology of SAD, and include a discussion of the differential diagnosis and frequent comorbidities associated with the disorder. Both trainees and active clinicians should appreciate the suggested questions aimed at differentiating SAD from other disorders. While many clinicians do not use any sort of objective measure when assessing patients, this is rapidly becoming the standard of care, and the authors outline both the clinician and patient-(self-)administered scales that might be employed in assessing SAD. Finally, the authors note that while there is no empirical evidence for the necessity or benefit of assessing suitability for CBT (or any other treatment for that matter), as experienced CBT practitioners they have found it to be useful both for clinicians and patients.
The authors provide a concise description of the most influential models of understanding the development and maintenance of SAD, with key points provided on useful tables. While the neurobiology of SAD is not yet well delineated, some mention of the current understanding of key brain circuits as well as the neurotransmitters and receptors that may be implicated in SAD could be useful, particularly in making the case for the biopsychosocial underpinnings of anxiety disorders.
An appropriate and thorough assessment of SAD is emphasized to drive management decisions. Evidence-based psychological strategies are described and also presented in table form. Another strength of this book is that information about pharmacological treatment is provided, including tabulated dosages. There is an error in escitalopram starting and maintenance doses; and later in the book the authors incorrectly suggest that venlafaxine does not have a discontinuation problem. Nonmedical CBT practitioners often appreciate having a better understanding of pharmacological treatments, particularly when their clients who are prescribed medications come to them with concerns. The authors recognize the role, and provide the evidence for, both pharmacological and psychological modalities in the treatment of SAD. Factors influencing treatment decisions may seem obvious to seasoned clinicians, but are invaluable for trainees and less experienced practitioners.
